 Ynetnews [1] |
Andromeda reports success in juvenile diabetes [2] trial
Globes Andromeda Biotech Ltd. today reported success in the Phase III clinical trial of its Diapep277 drug for the treatment of Type 1 (juvenile) diabetes. The trial met its primary and secondary endpoints, and was found to be effective and safe. … Andromeda diabetes phase III trial successful [1]Ynetnews all 19 news articles » [3] |
More details can be found at www.diabeteshowto.com [4]